Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P A Lambert

Showing results (91-100 of 161) with videos related to

Pageof 17
Sort By:
Biochemical Society Transactions|October 1, 1990
Active-site modelling of class I beta-lactamasesC A Toomer, P A Lambert, C E Sansom, et al.
Surgery|August 1, 1997
Antiproliferative and antiinvasive effects of carboxyamido-triazole on breast cancer cell linesP A Lambert, K D Somers, E C Kohn, et al.
The Journal of Antimicrobial Chemotherapy|November 1, 1996
Mathematical model of beta-lactam penetration into a biofilm of Pseudomonas aeruginosa while undergoing simultaneous inactivation by released beta-lactamasesG H Dibdin, S J Assinder, W W Nichols, et al.
Journal of Bacteriology|June 1, 1994
Siderophore activity of myo-inositol hexakisphosphate in Pseudomonas aeruginosaA W Smith, D R Poyner, H K Hughes, et al.
The Journal of Infection|November 1, 1986
Serodiagnosis of Streptococcus faecalis endocarditisP A Lambert, E J Aitchison, E G Smith, et al.
The Journal of Antimicrobial Chemotherapy|August 1, 1990
Rapid emergence of resistance in Pseudomonas aeruginosa in cystic fibrosis patients due to in-vivo selection of stable partially derepressed beta-lactamase producing strainsB Giwercman, P A Lambert, V T Rosdahl, et al.
The Journal of Hospital Infection|December 3, 1999
The genomic diversity of coagulase-negative staphylococci associated with nosocomial infectionsS Lang, M A Livesley, P A Lambert, et al.
Environmental Toxicology and Pharmacology|February 13, 2001
Preliminary in vitro toxicological evaluation of a series of 2-pyridylcarboxamidrazone candidate anti-tuberculosis compounds IIIM D. Coleman, D L. Rathbone, R Chima, et al.
L'Encephale|January 1, 1983
[Effects of gamma-vinyl GABA per os in 5 cases of hebephreno-catatonic schizophrenia]P A Lambert, J P Chabannnes, P Cantiniaux, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1984
[Neurological complications of tricyclic antidepressive agents]J P Chabannes, P A Lambert, H René-Aussedat, et al.
Pageof 17

Showing results (91-100 of 161) with videos related to

Sort By:
Pageof 17
Biochemical Society Transactions|October 1, 1990
Active-site modelling of class I beta-lactamasesC A Toomer, P A Lambert, C E Sansom, et al.
Surgery|August 1, 1997
Antiproliferative and antiinvasive effects of carboxyamido-triazole on breast cancer cell linesP A Lambert, K D Somers, E C Kohn, et al.
The Journal of Antimicrobial Chemotherapy|November 1, 1996
Mathematical model of beta-lactam penetration into a biofilm of Pseudomonas aeruginosa while undergoing simultaneous inactivation by released beta-lactamasesG H Dibdin, S J Assinder, W W Nichols, et al.
Journal of Bacteriology|June 1, 1994
Siderophore activity of myo-inositol hexakisphosphate in Pseudomonas aeruginosaA W Smith, D R Poyner, H K Hughes, et al.
The Journal of Infection|November 1, 1986
Serodiagnosis of Streptococcus faecalis endocarditisP A Lambert, E J Aitchison, E G Smith, et al.
The Journal of Antimicrobial Chemotherapy|August 1, 1990
Rapid emergence of resistance in Pseudomonas aeruginosa in cystic fibrosis patients due to in-vivo selection of stable partially derepressed beta-lactamase producing strainsB Giwercman, P A Lambert, V T Rosdahl, et al.
The Journal of Hospital Infection|December 3, 1999
The genomic diversity of coagulase-negative staphylococci associated with nosocomial infectionsS Lang, M A Livesley, P A Lambert, et al.
Environmental Toxicology and Pharmacology|February 13, 2001
Preliminary in vitro toxicological evaluation of a series of 2-pyridylcarboxamidrazone candidate anti-tuberculosis compounds IIIM D. Coleman, D L. Rathbone, R Chima, et al.
L'Encephale|January 1, 1983
[Effects of gamma-vinyl GABA per os in 5 cases of hebephreno-catatonic schizophrenia]P A Lambert, J P Chabannnes, P Cantiniaux, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1984
[Neurological complications of tricyclic antidepressive agents]J P Chabannes, P A Lambert, H René-Aussedat, et al.
Pageof 17